Sana Biotechnology presents preclinical data for in vivo CAR T therapy

May 12, 2026 4:05 PM

Sana Biotechnology Inc. (NASDAQ: SANA) presented preclinical data for its SG293 therapy at the American Society of Gene & Cell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found